Medirom Healthcare Reports November 2025 KPIs
Ticker: MRM · Form: 6-K · Filed: Dec 22, 2025 · CIK: 1819704
Sentiment: neutral
Topics: kpi, press-release, foreign-private-issuer
TL;DR
Medirom Healthcare dropped November KPIs on Dec 22nd.
AI Summary
Medirom Healthcare Technologies Inc. announced its Key Performance Indicators (KPIs) for November 2025 on December 22, 2025. The company, based in Tokyo, Japan, is a foreign private issuer filing a Form 6-K report.
Why It Matters
This filing provides investors with updated operational data for Medirom Healthcare Technologies Inc., allowing for a timely assessment of the company's performance.
Risk Assessment
Risk Level: low — This is a routine filing of operational data and does not appear to contain significant new financial or strategic information.
Key Players & Entities
- Medirom Healthcare Technologies Inc. (company) — Registrant
- December 22, 2025 (date) — Date of press release and filing
- November 2025 (date) — Period for KPIs
- 001-39809 (other) — SEC File Number
FAQ
What specific Key Performance Indicators (KPIs) were announced for November 2025?
The filing states that a press release was issued announcing major Key Performance Indicators (KPIs) for the month of November 2025, but the specific KPIs are not detailed within this Form 6-K itself.
When was the press release announcing the KPIs filed?
The press release announcing the KPIs for November 2025 was issued on December 22, 2025.
What is the principal executive office of Medirom Healthcare Technologies Inc.?
The principal executive office is located at 2-3-1 Daiba, Minato-ku, Tokyo 135-0091, Japan.
Does Medirom Healthcare Technologies Inc. file annual reports under Form 20-F or 40-F?
Medirom Healthcare Technologies Inc. files annual reports under Form 20-F, as indicated by the checkmark next to 'Form 20-F'.
What is the SEC file number for Medirom Healthcare Technologies Inc.?
The SEC file number for Medirom Healthcare Technologies Inc. is 001-39809.
Filing Stats: 287 words · 1 min read · ~1 pages · Grade level 13.4 · Accepted 2025-12-22 16:30:10
Filing Documents
- mrm-20251222x6k.htm (6-K) — 13KB
- mrm-20251222xex99d1.htm (EX-99.1) — 92KB
- mrm-20251222xex99d1001.jpg (GRAPHIC) — 4KB
- mrm-20251222xex99d1003.jpg (GRAPHIC) — 30KB
- mrm-20251222xex99d1004.jpg (GRAPHIC) — 32KB
- mrm-20251222xex99d1005.jpg (GRAPHIC) — 34KB
- mrm-20251222xex99d1006.jpg (GRAPHIC) — 29KB
- mrm-20251222xex99d1007.jpg (GRAPHIC) — 31KB
- mrm-20251222xex99d1008.jpg (GRAPHIC) — 37KB
- mrm-20251222xex99d1009.jpg (GRAPHIC) — 34KB
- 0001104659-25-123756.txt ( ) — 425KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MEDIROM HEALTHCARE TECHNOLOGIES INC. Date: December 22, 2025 By: /s/ Fumitoshi Fujiwara Name: Fumitoshi Fujiwara Title: Chief Financial Officer